Skip to main content

In vivo models of hepatitis B and C virus infection

Author(s): Winer, Benjamin Y; Ding, Qiang; Gaska, Jenna M; Ploss, Alexander

To refer to this page use:
Abstract: Globally, more than 500 million individuals are chronically infected with hepatitis B (HBV), delta (HDV), and/or C (HCV) viruses, which can result in severe liver disease. Mechanistic studies of viral persistence and pathogenesis have been hampered by the scarcity of animal models. The limited species and cellular host range of HBV, HDV, and HCV, which robustly infect only humans and chimpanzees, have posed challenges for creating such animal models. In this review, we will discuss the barriers to interspecies transmission and the progress that has been made in our understanding of the HBV, HDV, and HCV life cycles. Additionally, we will highlight a variety of approaches that overcome these barriers and thus facilitate in vivo studies of these hepatotropic viruses.
Publication Date: Jul-2016
Electronic Publication Date: 8-Apr-2016
Citation: Winer, Benjamin Y, Ding, Qiang, Gaska, Jenna M, Ploss, Alexander. (2016). In vivo models of hepatitis B and C virus infection. FEBS Letters, 590 (13), 1987 - 1999. doi:10.1002/1873-3468.12157
DOI: doi:10.1002/1873-3468.12157
ISSN: 0014-5793
Pages: 1987 - 1999
Type of Material: Journal Article
Journal/Proceeding Title: FEBS Letters
Version: Author's manuscript

Items in OAR@Princeton are protected by copyright, with all rights reserved, unless otherwise indicated.